Literature DB >> 14528919

13C enrichment of extracellular neurotransmitter glutamate in rat brain--combined mass spectrometry and NMR studies of neurotransmitter turnover and uptake into glia in vivo.

K Kanamori1, R W Kondrat, B D Ross.   

Abstract

13C-enrichment analysis of glutamate in the extracellular fluid (GLU(ECF): 2-3 microM) by gas-chromatography/mass-spectrometry (GCMS) was combined with in vivo NMR observation of whole-brain GLU (approximately10 mM) to study neurotransmitter uptake. Brain GLU C5 was 13C-enriched by intravenous [2,5-13C]glucose infusion. GLU(ECF) was collected by microdialysis from the cortico-striatal region of awake rats. The 13C-enrichment of basal dialysate GLU C5 during 0.75-1.25 hr of infusion was 0.263 +/- 0.01, very close to the enrichment of whole-brain GLU C5. The result strongly suggests that dialysate GLU consists predominantly of neurotransmitter GLU. For selective 13C-enrichment of neurotransmitter GLU, the whole-brain 13C-enrichment was followed by [12C]glucose infusion to chase 13C from the small glial GLU pool. This leaves [5-13C]GLU mainly in the large neuronal metabolic pool and the vesicular neurotransmitter pool. The uptake of synaptic [5-13C]GLU(ECF) into glia and metabolism to glutamine (GLN) were monitored in vivo by NMR observation of [5-13C,15N]GLN formed during 15NH4Ac infusion. The rate of GLN synthesis, derived from neurotransmitter GLU(ECF) (which provided 80-90% of the substrate) was 6.4 +/- 0.44 micromol/g/hr. Hence, the observed rate represents a reasonable estimate for the rate of glial uptake of GLU(ECF), a process that is crucial for protecting the brain from GLU excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14528919

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  9 in total

Review 1.  Probing Metabolism in the Intact Retina Using Stable Isotope Tracers.

Authors:  Jianhai Du; Jonathan D Linton; James B Hurley
Journal:  Methods Enzymol       Date:  2015-06-14       Impact factor: 1.600

Review 2.  Microdialysis as a tool in local pharmacodynamics.

Authors:  Yanjun Li; Joanna Peris; Li Zhong; Hartmut Derendorf
Journal:  AAPS J       Date:  2006-04-07       Impact factor: 4.009

Review 3.  13C MRS studies of neuroenergetics and neurotransmitter cycling in humans.

Authors:  Douglas L Rothman; Henk M De Feyter; Robin A de Graaf; Graeme F Mason; Kevin L Behar
Journal:  NMR Biomed       Date:  2011-08-31       Impact factor: 4.044

Review 4.  A review of flux considerations for in vivo neurochemical measurements.

Authors:  David W Paul; Julie A Stenken
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

5.  Comparison of Glutamate Turnover in Nerve Terminals and Brain Tissue During [1,6-13C2]Glucose Metabolism in Anesthetized Rats.

Authors:  Anant B Patel; James C K Lai; Golam I M Chowdhury; Douglas L Rothman; Kevin L Behar
Journal:  Neurochem Res       Date:  2016-12-26       Impact factor: 3.996

6.  Active and inactive metabolic pathways in tumor spheroids: determination by GC-MS.

Authors:  Michael G Hunnewell; Neil S Forbes
Journal:  Biotechnol Prog       Date:  2010 May-Jun

7.  Clinical NOE 13C MRS for neuropsychiatric disorders of the frontal lobe.

Authors:  Napapon Sailasuta; Larry W Robertson; Kent C Harris; Andrea L Gropman; Peter S Allen; Brian D Ross
Journal:  J Magn Reson       Date:  2008-09-17       Impact factor: 2.229

8.  Determination of the glutamate-glutamine cycling flux using two-compartment dynamic metabolic modeling is sensitive to astroglial dilution.

Authors:  Jun Shen; Douglas L Rothman; Kevin L Behar; Su Xu
Journal:  J Cereb Blood Flow Metab       Date:  2008-09-03       Impact factor: 6.200

9.  Modeling the glutamate-glutamine neurotransmitter cycle.

Authors:  Jun Shen
Journal:  Front Neuroenergetics       Date:  2013-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.